Group 1 - The core viewpoint of the articles highlights the recent performance and financial metrics of Tianchen Medical, indicating a decline in stock price and fluctuations in trading volume [1][2] - As of January 13, Tianchen Medical's stock price was 47.95 yuan per share, with a market capitalization of 3.891 billion yuan [1] - The company has experienced a year-to-date stock price decrease of 0.27%, with a 5-day decline of 2.16%, a 20-day decline of 4.99%, and a 60-day decline of 11.95% [1] Group 2 - For the period from January to September 2025, Tianchen Medical reported a revenue of 244 million yuan, representing a year-on-year growth of 20.66% [2] - The net profit attributable to the parent company for the same period was 71.9458 million yuan, showing a significant year-on-year increase of 68.29% [2] - The company has distributed a total of 211 million yuan in dividends since its A-share listing, with 179 million yuan distributed over the past three years [2]
天臣医疗跌2.02%,成交额5740.04万元,主力资金净流出545.27万元